Cancer-Associated Thrombosis on Bevacizumab: Risk of Recurrence and Bleeding When Bevacizumab Is Stopped or Continued.
Cancers (Basel)
; 15(15)2023 Jul 31.
Article
de En
| MEDLINE
| ID: mdl-37568708
Texte intégral:
1
Collection:
01-internacional
Base de données:
MEDLINE
Type d'étude:
Clinical_trials
/
Etiology_studies
/
Risk_factors_studies
Langue:
En
Journal:
Cancers (Basel)
Année:
2023
Type de document:
Article
Pays d'affiliation:
France
Pays de publication:
Suisse